Carregant...
Decreasing Trend in Mortality of Chronic Myelogenous Leukemia Patients After Introduction of Imatinib in Japan and the U.S.
PURPOSE. Although the impact of imatinib in improving survival outcomes in chronic myelogenous leukemia (CML) patients has been widely reported, its impact on mortality from CML has not been evaluated. A survival benefit demonstrated in clinical trials does not simply translate to a decrease in mort...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3528387/ https://ncbi.nlm.nih.gov/pubmed/22971523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0197 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|